| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 694001 | 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester | 0.0378615809326464 | 0.092139024 |
| NSC 694075 | Null | 0.0378615809326464 | 0.041460486 |
| NSC 697730 | Null | 0.0378615809326464 | 0.16703717 |
| NSC 703468 | Null | 0.0378615809326464 | -0.062303663 |
| NSC 718165 | Null | 0.0378615809326464 | 0.056102354 |
| NSC 726436 | 4,11-bis[[2-(methylamino)ethyl]amino]-1H-naphtho[2,3-f]indol e-5,10-dione | 0.0378615809326464 | 0.15560132 |
| NSC 727224 | 1-(3-diethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline | 0.0378615809326464 | -0.052877151 |
| NSC 727729 | 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one | 0.0378615809326464 | 0.14409325 |
| NSC 728084 | 7-Chloro-2-(thien-2-yl)carbonyl-3-trifluoromethylquinoxaline 1,4-dioxide | 0.0378615809326464 | 0.20305924 |
| NSC 730507 | Null | 0.0378615809326464 | 0.30580751 |